Hospital
Scott Regional Medical Center, INC.
Scott Regional Medical Center, INC. was paid $3.77M by Medicaid between Jan 2018 and Dec 2024, across 64 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
33Billing provider infoSCOTT REGIONAL MEDICAL CENTER, INC.
MORTON, MS 39117
MORTON, MS 39117
33aNPI1134278435assigned 01/09/2007
33bProvider typeCritical Access Hospital
28Total paid$3.77M
24GClaims85,657
24DCodes billed64
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Mississippi
Rank by total paid#19 of 32
Median peer was paid$3.94M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KENNEDY, DON controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,930 | $608K | |
| 2019 | 12,562 | $600K | |
| 2020 | 8,381 | $345K | |
| 2021 | 10,250 | $419K | |
| 2022 | 15,519 | $616K | |
| 2023 | 14,952 | $670K | |
| 2024incomplete | 11,063 | $517K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 6,481 | 5,380 | $893K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 5,599 | 4,178 | $857K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 2,709 | 1,957 | $522K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.0% | 2,206 | 1,916 | $189K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.2% | 3,593 | 2,878 | $159K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.7% | 1,661 | 1,303 | $138K |
| 87428 | 3.3% | 2,454 | 2,074 | $123K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 3.1% | 1,009 | 142 | $116K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 4,677 | 2,786 | $78K |
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 1,674 | 1,416 | $64K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 4,482 | 3,926 | $59K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 2,442 | 1,925 | $50K |
52 more codes
| 71045 | Radiologic examination, chest; single view | 1.3% | 1,608 | $49K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 572 | $48K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,169 | $36K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,010 | $35K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,241 | $35K |
| 80053 | Comprehensive metabolic panel | <1% | 5,161 | $34K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 487 | $33K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 356 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 934 | $32K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 908 | $32K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 218 | $19K |
| Q3014 | Telehealth originating site facility fee | <1% | 989 | $18K |
| 74018 | <1% | 253 | $11K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 385 | $11K |
| 83880 | <1% | 615 | $11K | |
| 81025 | <1% | 1,675 | $11K | |
| 84484 | <1% | 1,648 | $10K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,257 | $10K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 165 | $9K |
| 81001 | <1% | 3,445 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 955 | $6K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 25 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 786 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 357 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 57 | $3K |
| 87807 | <1% | 285 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 18 | $3K |
| 81003 | <1% | 1,688 | $3K | |
| 73560 | <1% | 55 | $2K | |
| 87077 | <1% | 410 | $2K | |
| 87186 | <1% | 374 | $2K | |
| 80305 | <1% | 186 | $2K | |
| 73630 | <1% | 35 | $1K | |
| 87634 | <1% | 14 | $884.52 | |
| 87088 | <1% | 136 | $881.52 | |
| 83690 | <1% | 162 | $857.48 | |
| 73030 | <1% | 17 | $654.00 | |
| 83605 | <1% | 173 | $610.83 | |
| 83735 | <1% | 364 | $588.39 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,566 | $356.84 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 32 | $352.29 |
| 82553 | <1% | 27 | $272.83 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 105 | $187.67 |
| 94761 | <1% | 99 | $138.49 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,098 | $131.51 |
| 82962 | <1% | 35 | $35.40 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 377 | $7.44 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 251 | $5.28 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 1,391 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 28 | $0.00 |
| J3490 | Unclassified drugs | 0% | 1,415 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKENNEDY, DON (REGIONAL CEO)
| Provider | Location | Paid |
|---|---|---|
| Rush Medical Foundation | Meridian, MS | $29.41M |
| Laird Hospital, INC. | Union, MS | $7.23M |
| Laird Hospital, INC. | Meridian, MS | $5.90M |
| Laird Hospital, INC | Meridian, MS | $5.27M |
| Rush Medical Foundation | Quitman, MS | $4.69M |
| Kemper, Cah, INC | Livingston, AL | $4.50M |
| Medical Foundation, INC. | Meridian, MS | $4.20M |
| Kemper Cah, INC. | De Kalb, MS | $4.06M |
| Kemper Cah, INC | Meridian, MS | $3.39M |
| Rush Hospital/Butler, INC | Butler, AL | $1.94M |
| Medical Foundation, INC. | Meridian, MS | $1.82M |
| The Medical Store, INC. | Meridian, MS | $1.66M |
| Rush Medical Foundation | Meridian, MS | $1.61M |
| Medical Foundation, INC. | Meridian, MS | $1.37M |
| Laird Hospital, INC. | Union, MS | $1.31M |
| Medical Foundation, INC. | Meridian, MS | $1.27M |
| Scott Regional Medical Center, INC. | Morton, MS | $1.21M |
| Rush Medical Foundation | Quitman, MS | $978K |
| Kemper Cah, INC | Meridian, MS | $910K |
| Laird Hospital, INC. | Philadelphia, MS | $898K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.